Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (DRKS00038006) titled 'Identification of cross-reactive microbiota against the prefusion F protein' on Sept. 26.
Study Type: observational
Study Design:
Allocation:
Masking:
Control:
Assignment:
Study design purpose: basic science
Primary Sponsor: Charite- Universitatsmedizin Berlin
Condition:
B97.4
Respiratory syncytial virus as the cause of diseases classified to other chapters
Intervention:
Group 1: In this study, saliva and blood samples will be collected from all enrolled participants at three time points during routine blood draws in the outpatient clinic: immediately before RSV vaccination (day 0), approximately one month aft...